Literature DB >> 33647278

Glucocorticoid receptor modulators decrease alcohol self-administration in male rats.

M Adrienne McGinn1, Brendan J Tunstall2, Joel E Schlosburg3, Adriana Gregory-Flores4, Olivier George5, Giordano de Guglielmo5, Barbara J Mason6, Hazel J Hunt7, George F Koob8, Leandro F Vendruscolo8.   

Abstract

Alcohol use disorder (AUD) is associated with the dysregulation of brain stress and reward systems, including glucocorticoid receptors (GRs). The mixed glucocorticoid/progesterone receptor antagonist mifepristone and selective GR antagonist CORT113176 have been shown to selectively reduce alcohol consumption in alcohol-dependent rats. Mifepristone has also been shown to decrease alcohol consumption and craving for alcohol in humans with AUD. The present study tested the effects of the GR modulators CORT118335, CORT122928, CORT108297, and CORT125134 on alcohol self-administration in nondependent (air-exposed) and alcohol-dependent (alcohol vapor-exposed) adult male rats. Different GR modulators recruit different GR-associated transcriptional cofactors. Thus, we hypothesized that these GR modulators would vary in their effects on alcohol drinking. CORT118335, CORT122928, and CORT125134 significantly reduced alcohol self-administration in both alcohol-dependent and nondependent rats. CORT108297 had no effect on alcohol self-administration in either group. The present results support the potential of GR modulators for the development of treatments for AUD. Future studies that characterize genomic and nongenomic effects of these GR modulators will elucidate potential molecular mechanisms that underlie alcohol drinking in alcohol-dependent and nondependent states. Published by Elsevier Ltd.

Entities:  

Keywords:  Addiction; Alcohol dependence; Alcohol drinking; Alcoholism

Mesh:

Substances:

Year:  2021        PMID: 33647278      PMCID: PMC8099171          DOI: 10.1016/j.neuropharm.2021.108510

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  51 in total

1.  Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats.

Authors:  Leandro F Vendruscolo; Estelle Barbier; Joel E Schlosburg; Kaushik K Misra; Timothy W Whitfield; Marian L Logrip; Catherine Rivier; Vez Repunte-Canonigo; Eric P Zorrilla; Pietro P Sanna; Markus Heilig; George F Koob
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

2.  A Mixed Glucocorticoid/Mineralocorticoid Selective Modulator With Dominant Antagonism in the Male Rat Brain.

Authors:  Erika Atucha; Ioannis Zalachoras; José K van den Heuvel; Lisa T C M van Weert; Diana Melchers; Isabel M Mol; Joseph K Belanoff; René Houtman; Hazel Hunt; Benno Roozendaal; Onno C Meijer
Journal:  Endocrinology       Date:  2015-08-25       Impact factor: 4.736

3.  Evaluation of mifepristone effects on alcohol-seeking and self-administration in baboons.

Authors:  August F Holtyn; Elise M Weerts
Journal:  Exp Clin Psychopharmacol       Date:  2018-12-20       Impact factor: 3.157

4.  Sex, strain, and estrous cycle influences on alcohol drinking in rats.

Authors:  Brittany M Priddy; Stephanie A Carmack; Lisa C Thomas; Janaina C M Vendruscolo; George F Koob; Leandro F Vendruscolo
Journal:  Pharmacol Biochem Behav       Date:  2016-08-04       Impact factor: 3.533

5.  Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery.

Authors:  Travis T Wager; Xinjun Hou; Patrick R Verhoest; Anabella Villalobos
Journal:  ACS Chem Neurosci       Date:  2016-04-04       Impact factor: 4.418

6.  Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.

Authors:  Masis Isikbay; Kristen Otto; Steven Kregel; Jacob Kach; Yi Cai; Donald J Vander Griend; Suzanne D Conzen; Russell Z Szmulewitz
Journal:  Horm Cancer       Date:  2014-03-11       Impact factor: 3.869

7.  Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist.

Authors:  Hazel J Hunt; Joseph K Belanoff; Iain Walters; Benoit Gourdet; Jennifer Thomas; Naomi Barton; John Unitt; Timothy Phillips; Denise Swift; Emily Eaton
Journal:  J Med Chem       Date:  2017-04-17       Impact factor: 7.446

Review 8.  Operant alcohol self-administration in dependent rats: focus on the vapor model.

Authors:  Leandro F Vendruscolo; Amanda J Roberts
Journal:  Alcohol       Date:  2013-11-01       Impact factor: 2.405

9.  The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test.

Authors:  Matia B Solomon; Aynara C Wulsin; Taylor Rice; Dayna Wick; Brent Myers; Jessica McKlveen; Jonathan N Flak; Yvonne Ulrich-Lai; James P Herman
Journal:  Horm Behav       Date:  2014-02-11       Impact factor: 3.587

Review 10.  Corticosteroid Receptors in the Brain: Transcriptional Mechanisms for Specificity and Context-Dependent Effects.

Authors:  Onno C Meijer; J C Buurstede; Marcel J M Schaaf
Journal:  Cell Mol Neurobiol       Date:  2018-10-05       Impact factor: 5.046

View more
  7 in total

1.  Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies.

Authors:  Mehdi Farokhnia; Christopher T Rentsch; Vicky Chuong; M Adrienne McGinn; Sophie K Elvig; Eliza A Douglass; Luis A Gonzalez; Jenna E Sanfilippo; Renata C N Marchette; Brendan J Tunstall; David A Fiellin; George F Koob; Amy C Justice; Lorenzo Leggio; Leandro F Vendruscolo
Journal:  Mol Psychiatry       Date:  2022-09-20       Impact factor: 13.437

2.  Corticosteroid sensitization drives opioid addiction.

Authors:  Stephanie A Carmack; Janaina C M Vendruscolo; M Adrienne McGinn; Jorge Miranda-Barrientos; Vez Repunte-Canonigo; Gabriel D Bosse; Daniele Mercatelli; Federico M Giorgi; Yu Fu; Anthony J Hinrich; Francine M Jodelka; Karen Ling; Robert O Messing; Randall T Peterson; Frank Rigo; Scott Edwards; Pietro P Sanna; Marisela Morales; Michelle L Hastings; George F Koob; Leandro F Vendruscolo
Journal:  Mol Psychiatry       Date:  2022-03-16       Impact factor: 13.437

3.  Circulating corticosterone levels mediate the relationship between acute ethanol intoxication and markers of NF-κB activation in male rats.

Authors:  Thaddeus M Barney; Andrew S Vore; Sarah L Trapp; Cristal L Finkenberg; Dominique R Pugliesi; Megha M Schmalzle; Shani H Evans; Elena I Varlinskaya; Terrence Deak
Journal:  Neuropharmacology       Date:  2022-03-24       Impact factor: 5.273

4.  Corticosterone Levels and Glucocorticoid Receptor Gene Expression in High Drinking in the Dark Mice and Their Heterogeneous Stock (HS/NPT) Founder Line.

Authors:  Antonia M Savarese; Kolter B Grigsby; Bryan E Jensen; Marissa B Borrego; Deborah A Finn; John C Crabbe; Angela R Ozburn
Journal:  Front Behav Neurosci       Date:  2022-05-12       Impact factor: 3.617

5.  Alcohol dependence and withdrawal increase sensitivity of central amygdalar GABAergic synapses to the glucocorticoid receptor antagonist mifepristone in male rats.

Authors:  Sophia Khom; Larry Rodriguez; Pauravi Gandhi; Dean Kirson; Michal Bajo; Christopher S Oleata; Leandro F Vendruscolo; Barbara J Mason; Marisa Roberto
Journal:  Neurobiol Dis       Date:  2022-01-04       Impact factor: 7.046

6.  Pairing Binge Drinking and a High-Fat Diet in Adolescence Modulates the Inflammatory Effects of Subsequent Alcohol Consumption in Mice.

Authors:  Macarena González-Portilla; Sandra Montagud-Romero; Francisco Navarrete; Ani Gasparyan; Jorge Manzanares; José Miñarro; Marta Rodríguez-Arias
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

7.  DNA methylation of the glucocorticoid receptor gene predicts substance use in adolescence: longitudinal data from over 1000 young individuals.

Authors:  Elena Raffetti; Philippe Anastasios Melas; Anton Jonatan Landgren; Filip Andersson; Yvonne Forsell; Catharina Lavebratt; Maria Rosaria Galanti
Journal:  Transl Psychiatry       Date:  2021-09-15       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.